Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Relation of incident Type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland

Paul M McKeigue, Stuart McGurnaghan, Luke Blackbourn, Louise E Bath, David A McAllister, Thomas M Caparrotta, Sarah H Wild, Simon N Wood, Diane Stockton, View ORCID ProfileHelen M Colhoun
doi: https://doi.org/10.1101/2022.02.11.22270785
Paul M McKeigue
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
2Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart McGurnaghan
3Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XU, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luke Blackbourn
3Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XU, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise E Bath
4Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A McAllister
5Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ, Scotland
2Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas M Caparrotta
3Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XU, Scotland
4Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah H Wild
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
2Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon N Wood
6School of Mathematics, James Clerk Maxwell Building, University of Edinburgh, EH9 3FD, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Stockton
2Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen M Colhoun
3Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XU, Scotland
2Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helen M Colhoun
  • For correspondence: helen.colhoun@ed.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Studies using claims databases have reported that SARS-CoV-2 infection >30 days earlier increased the incidence of type 1 diabetes (T1DM). Using exact dates of type 1 diabetes diagnosis from the national register in Scotland linked to virology laboratory data we sought to replicate this finding.

Methods A cohort of 1849411 individuals aged <35 years without diabetes, including all those in Scotland who subsequently tested positive for SARS-CoV-2, was followed from 1 March 2020 to 22 November 2021. Incident T1DM was identified by linkage to the national registry. Cox regression was used to test the association of time-updated infection with incident T1DM. Trends in incidence of T1DM in the total population from 2015-2021 were estimated in a generalized additive model.

Findings There were 365080 in the cohort with at least one detected SARS-CoV-2 infection during follow-up and 1074 who developed T1DM. The rate ratio for incident T1DM associated with first positive test for SARS-CoV-2 (with no previous infection as reference category) was 0.88 (95% CI 0.63 to 1.23) for infection more than 30 days earlier and 2.62 (95% CI 1.81 to 3.79) for infection in the previous 30 days. However negative and positive SARS-CoV-2 tests were more frequent in the days surrounding T1DM presentation. In those aged 0-14 years incidence of T1DM during 2020-2021 was 20% higher than the 7-year average.

Interpretation T1DM incidence in children increased during the pandemic. However the cohort analysis does not support a causal effect of SARS-CoV-2 infection itself on T1DM incidence.

Funding None

Competing Interest Statement

HC Advisory Board: Novo-Nordisk, Bayer, Eli Lilly, Regeneron, Astra Zeneca, Meeting attendance support: Novo Nordisk, Eli Lilly, Regeneron, Stock: Bayer Roche Grant Research Funding Diabetes UK,Juvenile Diabetes Research Foundation, AXA Research Fund. PMCK Stock: Bayer Roche. SW Meeting attendance support: Novo Nordisk. TC Grant Supprt Diabetes UK, Leadership: Edinburgh High Blood Pressure Fund Trustee

Clinical Protocols

https://osf.io/rfzk7/

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Approval for use of the diabetes data was provided by the Public Benefit and Privacy Panel (https://www.informationgovernance.scot.nhs.uk/pbpphsc/) (ref. 1617-0147) and the Scotland A Multicentre Research Ethics Committee (ref 21/WS/0047). The REACT-SCOT study was performed within Public Health Scotland as part of its statutory duty to monitor and investigate public health problems and pandemic response. Under the [UK Policy Framework for Health and Social Care Research](https://www.hra.nhs.uk/planning-and-improving-research/policies-standards-legislation/uk-policy-framework-health-social-care-research/) set out by the NHS Health Research Authority, this does not fall within the definition of research and ethical review was therefore not required. This has been confirmed in writing by the NHS West of Scotland Research Ethics Service. Individual consent is not required for Public Health Scotland staff to process personal data to perform specific tasks in the public interest that fall within its statutory role. The statutory basis for this is set out in Public Health Scotland's [privacy notice](https://www.publichealthscotland.scot/our-privacy-notice/personal-data-processing/).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The component datasets used here are available to researchers via application to the Public Benefits and Privacy Panel for Health and Social Care https://www.informationgovernance.scot.nhs.uk/pbpphsc/

https://www.informationgovernance.scot.nhs.uk/pbpphsc/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted February 11, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Relation of incident Type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Relation of incident Type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland
Paul M McKeigue, Stuart McGurnaghan, Luke Blackbourn, Louise E Bath, David A McAllister, Thomas M Caparrotta, Sarah H Wild, Simon N Wood, Diane Stockton, Helen M Colhoun
medRxiv 2022.02.11.22270785; doi: https://doi.org/10.1101/2022.02.11.22270785
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Relation of incident Type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland
Paul M McKeigue, Stuart McGurnaghan, Luke Blackbourn, Louise E Bath, David A McAllister, Thomas M Caparrotta, Sarah H Wild, Simon N Wood, Diane Stockton, Helen M Colhoun
medRxiv 2022.02.11.22270785; doi: https://doi.org/10.1101/2022.02.11.22270785

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (241)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1426)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (586)
  • Epidemiology (10307)
  • Forensic Medicine (6)
  • Gastroenterology (528)
  • Genetic and Genomic Medicine (2637)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1740)
  • Health Policy (790)
  • Health Systems and Quality Improvement (676)
  • Hematology (268)
  • HIV/AIDS (568)
  • Infectious Diseases (except HIV/AIDS) (12103)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2466)
  • Nursing (145)
  • Nutrition (379)
  • Obstetrics and Gynecology (493)
  • Occupational and Environmental Health (568)
  • Oncology (1327)
  • Ophthalmology (403)
  • Orthopedics (147)
  • Otolaryngology (238)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (784)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2405)
  • Public and Global Health (5019)
  • Radiology and Imaging (895)
  • Rehabilitation Medicine and Physical Therapy (530)
  • Respiratory Medicine (682)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (246)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)